Clinical trials carefully assess whether each interested person is eligible to participate. This is done for two main reasons: 1) to protect the health and safety of people who wish to enroll, and 2) to protect the scientific integrity of the study.
Like most clinical trials, the AHEAD 3-45 Study has specific inclusion criteria - such as being a certain age or having a study partner – and exclusion criteria – such as not having certain medical conditions.
Please answer the following 6 questions to find out if you might be eligible to screen for the AHEAD 3-45 Study. This should only take a few minutes to complete. At the end, you will be told if you may be eligible and will be given contact information for a site near you, for which you can choose to contact directly or have your contact information shared with the site.
Thank you for taking the time to answer these questions. Unfortunately, the answers you provided indicate that you are not likely to be eligible to participate in the AHEAD 3-45 Study at this time. Participants in the AHEAD 3-45 Study must be between 55 and 80, cannot have a diagnosis of Alzheimer’s disease, mild cognitive impairment (MCI), or another cognitive or neurological disorder, cannot have a pacemaker or other medical device that prevents having MRIs, and must have a person with whom they have weekly contact who can serve in the important role of “study partner.”
However, there may be opportunities for you to participate in future studies.